The Sidney Kimmel Comprehensive Cancer Center
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Employees
- -
- Market Cap
- -
Imatinib Mesylate in Treating Patients With Recurrent Malignant Glioma or Meningioma
- Conditions
- Brain and Central Nervous System Tumors
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2018-06-27
- Target Recruit Count
- 105
- Registration Number
- NCT00010049
- Locations
- 🇺🇸
UCSF Comprehensive Cancer Center, San Francisco, California, United States
🇺🇸Hillman Cancer Center at University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States
🇺🇸Simmons Cancer Center at University of Texas Southwestern Medical Center - Dallas, Dallas, Texas, United States
Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2018-06-26
- Target Recruit Count
- 105
- Registration Number
- NCT00025675
- Locations
- 🇺🇸
NCI - Neuro-Oncology Branch, Bethesda, Maryland, United States
🇺🇸Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, California, United States
Phenylbutyrate and Tretinoin in Treating Patients With Hematologic Cancer
- Conditions
- Myelodysplastic SyndromesLeukemiaMyelodysplastic/Myeloproliferative Diseases
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
Benzoylphenylurea in Treating Patients With Advanced Solid Tumors
- Conditions
- Unspecified Adult Solid Tumor, Protocol Specific
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-03-25
- Target Recruit Count
- 19
- Registration Number
- NCT00016354
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
Pyrazoloacridine Followed by Radiation Therapy in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme
- Conditions
- Brain and Central Nervous System Tumors
- Locations
- 🇺🇸
Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸Winship Cancer Institute of Emory University, Atlanta, Georgia, United States
🇺🇸Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
UCN-01 and Irinotecan in Treating Patients With Advanced Solid Tumors
- Conditions
- Unspecified Adult Solid Tumor, Protocol Specific
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2010-08-09
- Target Recruit Count
- 30
- Registration Number
- NCT00047242
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
Tipifarnib in Treating Patients With Recurrent or Progressive Malignant Glioma
- Conditions
- Brain and Central Nervous System Tumors
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2018-06-26
- Target Recruit Count
- 136
- Registration Number
- NCT00005859
- Locations
- 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
🇺🇸Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States
🇺🇸UCSF Comprehensive Cancer Center, San Francisco, California, United States
Biological Therapy and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2018-07-18
- Target Recruit Count
- 31
- Registration Number
- NCT00052715
- Locations
- 🇺🇸
UCSF Comprehensive Cancer Center, San Francisco, California, United States
Celecoxib Compared With No Treatment Before Surgery in Treating Patients With Localized Prostate Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2019-02-08
- Target Recruit Count
- 73
- Registration Number
- NCT00022399
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
Chemotherapy, Vaccine Therapy, and Stem Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma
- Conditions
- Multiple Myeloma
- Interventions
- Biological: GVAXProcedure: Autologous transplant
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2018-09-19
- Target Recruit Count
- 28
- Registration Number
- NCT00024466
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States